We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+31.28%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.82B
AUM Growth
+$324M
Cap. Flow
-$120M
Cap. Flow %
-6.62%
Top 10 Hldgs %
36.31%
Holding
2,419
New
1,036
Increased
430
Reduced
305
Closed
497

Top Buys

Rank Stock Value
1
SHYG icon
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
+$24M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$7.59M
3
CZR
Caesars Entertainment Corporation
CZR
+$5.85M
4
AVGO icon
Broadcom
AVGO
+$5.1M
5
ACIA
Acacia Communications Inc
ACIA
+$3.72M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$16.1M
2
WBC
WABCO HOLDINGS INC.
WBC
+$11.4M
3
FTSV
Forty Seven, Inc. Common Stock
FTSV
+$11.3M
4
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$10.3M
5
MU icon
Micron Technology
MU
+$8.71M

Sector Composition

Rank Sector Weight
1 Technology 6.98%
2 Consumer Discretionary 5.02%
3 Healthcare 3.42%
4 Financials 2.97%
5 Industrials 2.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MKL icon
551
CALL
Markel Group
MKL
$23.2B
$369K 0.02%
400
-300
-43% -$273K
GBT
552
DELISTED
Global Blood Therapeutics, Inc.
GBT
$369K 0.02%
+5,850
New +$401K
GME icon
553
GameStop
GME
$8.6B
$368K 0.02%
+339,440
New +$392K
FLXN
554
DELISTED
Flexion Therapeutics, Inc.
FLXN
$368K 0.02%
28,000
+25,500
+1,020% +$264K
ARCT icon
555
Arcturus Therapeutics
ARCT
$211M
$365K 0.02%
7,800
-23,539
-75% -$811K
WING icon
556
Wingstop
WING
$3.18B
$365K 0.02%
+2,630
New +$307K
CRSP icon
557
CRISPR Therapeutics
CRSP
$5.17B
$364K 0.02%
+4,950
New +$289K
SBUX icon
558
Starbucks
SBUX
$120B
$362K 0.02%
4,924
-1,579
-24% -$119K
KPTI icon
559
Karyopharm Therapeutics
KPTI
$48M
$360K 0.02%
+1,268
New +$375K
OXY icon
560
PUT
Occidental Petroleum
OXY
$55.9B
$359K 0.02%
19,600
-30,900
-61% -$487K
GPRO icon
561
GoPro
GPRO
$126M
$357K 0.02%
+75,000
New +$285K
TEAM icon
562
Atlassian
TEAM
$37.8B
$357K 0.02%
1,978
+1,442
+269% +$239K
BIIB icon
563
Biogen
BIIB
$30.7B
$356K 0.02%
1,331
-1,045
-44% -$314K
DLB icon
564
Dolby
DLB
$5.79B
$356K 0.02%
+5,397
New +$323K
SAGE
565
DELISTED
Sage Therapeutics
SAGE
$354K 0.02%
+8,502
New +$309K
CALY
566
Callaway Golf Company
CALY
$3.14B
$352K 0.02%
20,124
-9,261
-32% -$129K
KLAC icon
567
PUT
KLA
KLAC
$259B
$350K 0.02%
18,000
– –
DNKN
568
DELISTED
Dunkin' Brands Group, Inc.
DNKN
$350K 0.02%
+5,361
New +$334K
BC icon
569
Brunswick
BC
$5.28B
$349K 0.02%
+5,453
New +$272K
XEC
570
DELISTED
CIMAREX ENERGY CO
XEC
$348K 0.02%
12,647
+10,385
+459% +$258K
XEL icon
571
Xcel Energy
XEL
$48.8B
$347K 0.02%
5,559
+3,188
+134% +$201K
ECHO
572
DELISTED
Echo Global Logistics, Inc.
ECHO
$347K 0.02%
+16,027
New +$301K
GAP
573
The Gap Inc
GAP
$7.37B
$346K 0.02%
+27,416
New +$247K
AVYA
574
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$346K 0.02%
+27,976
New +$322K
EGIO
575
DELISTED
Edgio, Inc. Common Stock
EGIO
$345K 0.02%
1,173
-11,750
-91% -$2.61M
21 22
23
24 25

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Prelude Capital Management held 2,419 positions worth $1.82B, up 22% from $1.49B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Prelude Capital Management withdrew a net $120M in Q2 2020, closing 497 positions and reducing 305 holdings. Its most notable exit was Allergan plc, an estimated $16.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7% of assets, up from 6.3% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in iShares 0-5 Year High Yield Corporate Bond ETF worth $24.4M.

  • Prelude Capital Management's largest Q2 2020 buy was iShares 0-5 Year High Yield Corporate Bond ETF: 568,440 shares worth $24.4M.
  • Prelude Capital Management added most to Acacia Communications Inc in Q2 2020, an estimated $3.72M increase.
  • Prelude Capital Management's biggest Q2 2020 reduction was Micron Technology, cutting an estimated $8.71M.
  • Prelude Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $16.1M.
  • Prelude Capital Management's ten largest holdings make up 36% of its $1.82B portfolio in Q2 2020.
  • Prelude Capital Management opened 1,036 new positions and closed 497 in Q2 2020.
  • Prelude Capital Management's portfolio value rose 22% quarter-over-quarter to $1.82B.

Based on Prelude Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.